Detail akcie iRadimed online

Business Summary: IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories and services. Its MRidium 3860+ MRI Compatible IV infusion pump system provides non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium MRI compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to deliver anesthesia safely and predictably and other IV medications or fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to monitor a patient’s vital signs safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably in magnetic fields up to 30,000 gausses.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Iradimed Corp revenues increased 23% to $65.6M. Net income increased 34% to $17.2M. Revenues reflect United States segment increase of 20% to $52.5M, International segment increase of 39% to $13M. Net income benefited from Interest Income increase from $582K to $1.9M (income), Sales and marketing - Balancing value decrease of 5% to $11.6M (expense).